Ancient humans probably kept drinking milk despite lactose intolerance

Publicly released:
International

Much like us, prehistoric people in Europe probably soldiered on despite a lactose intolerance, according to international researchers who looked at milk consumption in ancient humans across Europe. The team built a map of prehistoric milk consumption by analysing animal fat residues derived from just over 13,000 fragments of pottery found at 554 archaeological sites, and found milk use was probably widespread in Europe from the Neolithic Period onwards (around 7,000 BCE). The team also looked at the frequency of the main lactase persistence gene (the enzyme that digests milk) among Eurasians through time, and found the enzyme was not common until around 1,000 BCE. Together, these findings indicate that in Europe milk use was widespread when prehistoric people were still largely lactose intolerant, raising questions about whether milk consumption is a key driver for lactase persistence. So next time you’re riding the porcelain train to Poop-town after a big milkshake, look up at the sky and feel that connection to generations before you.

Media release

From: Springer Nature

Ancient humans were consuming milk long before they could digest it (N&V)

Prehistoric people in Europe may have started consuming milk from domesticated animals thousands of years before they evolved the gene to digest it, suggests a study published in Nature. The findings offer new insights into milk consumption and the evolution of lactose tolerance.

It is believed that milk consumption in ancient humans played an important role in the evolution of the persistence of the lactase enzyme in adults, which enables the digestion of lactose from milk. However, considerable uncertainty remains because the intensity of milk consumption can vary a lot by geography and through time. To further explore the co-evolution of dairy farming and lactase persistence, Richard Evershed and colleagues built a comprehensive map of prehistoric milk consumption by analysing 6,899 animal fat residues derived from 13,181 fragments of pottery from 554 archaeological sites. The evidence suggests that milk use was widespread in Europe from the Neolithic period onwards (from around 7,000 BC) but varied across different regions and times. They also examined the frequency of the main lactase persistence gene variant among Eurasians through time, based on published ancient DNA data from 1,786 prehistoric European and Asian individuals. The results showed that lactase persistence was not common until around 1,000 BC, nearly 4,000 years after it was first detected around 4,700–4,600 BC.

Together, these findings indicate that in Europe milk use was widespread when prehistoric people were still largely lactose intolerant, raising questions about whether milk consumption is a key driver for lactase persistence. Modelling genetic and archaeological data did not show a strong link between milk consumption and the rise of lactase persistence either, the authors add. Instead, they found that indicators for famine and pathogen exposure better explained its evolution. The findings of the study challenge the prevailing narrative about how the lactase persistence gene evolved, and provide new perspectives for future research into other plausible hypotheses, the authors conclude.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research Springer Nature, Web page The URL will go live after the embargo lifts.
Journal/
conference:
Nature
Research:Paper
Organisation/s: University of Bristol, UK
Funder: This study was funded by the European Research Council (ERC) Advanced Grant ‘NeoMilk’ FP7-IDEAS-ERC/324202. M.R.-S. thanks the Royal Society for funding her Dorothy Hodgkin Fellowship (DHF\R1\180064 and RGF\EA\181067). NERC are thanked for partial funding of the National Environmental Isotope Facility (NEIF; NE/ V003917/1). We wish to thank the NERC (NE/V003917/1), the ERC (FP7-IDEAS-ERC/340923) and the University of Bristol for funding GC–MS and GC–IRMS capabilities used for this work. Y.D. and M.G.T. received funding from the ERC Horizon 2020 research and innovation programme (grant agreement no. 788616 YMPACT) and A.T. and M.G.T. received funding from the ERC Horizon 2020 research and innovation programme (grant agreement no. 951385 COREX). G.D.S. and M.S.L. work in the MRC Integrative Epidemiology Unit at the University of Bristol (MC_UU_00011/1). P. Bickle (University of York, UK) and D. Altoft are acknowledged for the sampling of some potsherds from this study.
Media Contact/s
Contact details are only visible to registered journalists.